Consultant.
No. 9
Strategies to Lower the Risk of Stroke-Related Dementia
December 31, 2006
What is the risk of dementia in patients who have had an ischemic stroke?
And which therapies are most effective in reducing this risk?
—— MD
Population-based epidemiologic studies show that
the risk of dementia is 4 to 6 times higher in patients
who have had a stroke than in those who
have not.1 In hospitalized cohorts, dementia develops
in a quarter to a third of patients 3 months after
a stroke,2 and up to 60% have impairment in at least 1 cognitive
domain. Compared with persons who have not had
a stroke, patients with cerebrovascular disease have a 2- to
10-fold higher risk of incident dementia, particularly when
multiple infarcts are present.3 In the general population,
silent or unrecognized brain infarcts also raise the risk of
dementia in the subsequent 3 years,4 perhaps because
they are a marker of high risk of additional infarcts.5
Cognitive decline in patients with cerebrovascular
disease can result from the stroke itself when a large volume
of brain is affected by ischemia or hemorrhage or
when the lesion, because of its location in a strategic area,
interrupts brain circuits that are critical for cognition.
Alternatively, vascular and neurodegenerative changes,
which are common in the brains of elderly persons,6 can
coexist and lead to a “mixed dementia.” These pathologic
processes act synergistically to impair cognition.7
Clearly, strategies that reduce the incidence of stroke
will reduce the burden of cognitive impairment and dementia.
Primary prevention strategies for stroke include lifestyle
changes (a healthful diet, regular exercise, smoking
cessation) and aggressive management of risk factors, including
hypertension, nonvalvular atrial fibrillation, and hypercholesterolemia.
8 Proven secondary prevention strategies
include the use of antihypertensive agents, particularly
angiotensin-converting enzyme inhibitors and thiazide diuretics,
9,10 and antiplatelet agents, as well as management of
atrial fibrillation and symptomatic high-grade carotid artery
stenosis. Data from available studies suggest that statin
therapy may reduce the risk of stroke by 25%.11 Trials to
test the effectiveness of statins in secondary stroke prevention
are currently under way, as are trials of vitamin therapy
to reduce homocysteine levels.
—— José G. Merino, MD
Assistant Professor of Neurology
University of Florida College of Medicine
Jacksonville
REFERENCES:
1. Zhu L, Fratiglioni L, Guo Z, et al. Association of stroke with dementia, cognitive
impairment, and functional disability in the very old: a population-based
study. Stroke. 1998;29:2094-2099.
2. Tatemichi TK, Desmond DW, Mayeux R, et al. Dementia after stroke: baseline
frequency, risks and clinical features in a hospitalized cohort. Neurology.
1992;42:1185-1193.
3. Schneider JA, Wilson RS, Cochran EJ, et al. Relation of cerebral infarctions to
dementia and cognitive function in older persons. Neurology. 2003;60:1082-1088.
4. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of
dementia and cognitive decline. N Engl J Med. 2003;348:1215-1222.
5. Breteler MM. Vascular risk factors for Alzheimer’s disease: an epidemiologic
perspective. Neurobiol Aging. 2000;21:153-160.
6. Neuropathology Group. Medical Research Council Cognitive Function and
Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a
multicentre, community-based population in England and Wales. Lancet. 2001;
357:169-175.
7. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical
expression of Alzheimer disease. The Nun Study. JAMA. 1997;277:813-817.
8. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention:
scientific review. JAMA. 2002;288:1388-1395.
9. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme
inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes
Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
10. Randomised trial of a perindopril-based blood-pressure-lowering regimen
among 6,105 individuals with previous stroke or transient ischaemic attack.
Lancet. 2001;358:1033-1041.
11. Collins R, Armitage J, Parish S, et al. Effects of cholesterol-lowering
simvastatin on stroke and other major vascular events in 20536 people with
cerebrovascular disease or other high-risk conditions. Lancet. 2004;363:757-767.
|
Five Steps to Improving Patient Access Judy Capko, May 21, 2013 Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Find peer-reviewed literature and websites for practicing medical professionals
|